Across
- 3. This specific histologic subtype of renal cell carcinoma is characterized by a papillary growth pattern and is often associated with a better prognosis. (13 letters)
- 5. Patients with advanced renal cell carcinoma may benefit from Pazopanib as it inhibits _____, the process of blood vessel formation. (12 letters)
- 7. This class of drugs, to which Pazopanib belongs, targets cellular signals to inhibit tumor growth. (6 letters)
- 8. A common imaging technique used to diagnose renal cancer. (7 letters)
- 9. One of the common side effects of Pazopanib, affecting the liver and may require monitoring.
Down
- 1. A genetic condition that increases the risk of renal cell carcinoma, often characterized by the development of benign tumors in multiple organs, is known as ____________________. (15 letters)
- 2. A phase III clinical trial, Pazopanib demonstrated superior progression-free survival compared to a placebo in patients with advanced renal cell carcinoma. The trial was known as the __________ trial. (8 letters)
- 4. One of the key targeted receptors for Pazopanib. (10 letters)
- 6. A subtype of an exceedingly rare tumor that originates from neural crest cells and is histologically characterized by clear cells that contain accumulated glycogen. (9 letters)